Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

IRON

Disc Medicine Inc

Apr 25 • 04:00PM ET

26.52

Dollar change -0.78
Percentage change -2.86	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM VHT IBB VTWO LABU IWO DWAS SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.50	Insider Own	48.05%	Shs Outstand	24.68M	Perf Week	-11.66%
Market Cap	654.51M	Forward P/E	-	EPS next Y	-5.26	Insider Trans	-13.24%	Shs Float	12.82M	Perf Month	-56.02%
Income	-76.43M	PEG	-	EPS next Q	-1.01	Inst Own	51.84%	Short Float	14.93%	Perf Quarter	-58.10%
Sales	0.00M	P/S	-	EPS this Y	-26.02%	Inst Trans	4.10%	Short Ratio	4.21	Perf Half Y	-40.75%
Book/sh	14.87	P/B	1.78	EPS next Y	-22.14%	ROA	-26.90%	Short Interest	1.91M	Perf Year	-11.75%
Cash/sh	14.60	P/C	1.82	EPS next 5Y	-	ROE	-29.30%	52W Range	25.60 - 77.60	Perf YTD	-54.09%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-21.20%	52W High	-65.82%	Beta	0.40
Dividend TTM	-	Quick Ratio	25.96	Sales past 5Y	0.00%	Gross Margin	-	52W Low	3.59%	ATR (14)	2.88
Dividend Ex-Date	-	Current Ratio	17.06	EPS Y/Y TTM	50.94%	Oper. Margin	0.00%	RSI (14)	21.60	Volatility	6.03% 7.67%
Employees	-	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.33	Target Price	57.11
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	19.77%	Payout	-	Rel Volume	0.69	Prev Close	27.30
Sales Surprise	-	EPS Surprise	-16.70%	Sales Q/Q	-	Earnings	Mar 21 BMO	Avg Volume	455.18K	Price	26.52
SMA20	-20.73%	SMA50	-49.65%	SMA200	-50.22%	Trades		Volume	314,533	Change	-2.86%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform	$40
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$56 → $65
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy	$50 → $75
Jun-07-23	Initiated	H.C. Wainwright	Buy	$55
May-17-23	Initiated	Raymond James	Outperform	$50
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight	$45
Apr-21-23	Initiated	Stifel	Buy	$37
Apr-20-23	Initiated	Morgan Stanley	Overweight	$37
Mar-23-23	Initiated	BMO Capital Markets	Outperform	$40
Feb-28-23	Initiated	SVB Securities	Outperform	$36

Apr-02-24 02:24PM	Disc Medicine (IRON) Down on Mixed Results From AURORA Study (Zacks) -6.36%
Apr-01-24 04:19PM	Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study (Investor's Business Daily) -45.05%
08:00AM	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) (GlobeNewswire)
Mar-23-24 05:31AM	Disc Medicine Inc (IRON) Reports Earnings: A Detailed Look at Fiscal Performance (GuruFocus.com)
Mar-21-24 08:00AM	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.52%
04:30PM	Loading…
Mar-06-24 04:30PM	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 (GlobeNewswire)
Feb-26-24 08:30AM	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer (GlobeNewswire)
Feb-20-24 08:30AM	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease (GlobeNewswire)
Feb-09-24 09:00AM	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera (GlobeNewswire)
Feb-07-24 08:00AM	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer (GlobeNewswire)
Jan-03-24 05:00PM	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-23 06:35PM	Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:30PM	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board (GlobeNewswire)
Dec-15-23 03:01PM	Insider Sell Alert: Director William White Sells 33,511 Shares of Disc Medicine Inc (IRON) (GuruFocus.com)
Dec-11-23 08:30PM	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
12:00PM	Loading…
12:00PM	Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Dec-08-23 07:06AM	Insider Sell Alert: CFO Joanne Bryce Sells 2,541 Shares of Disc Medicine Inc (IRON) (GuruFocus.com) +5.98%
Nov-14-23 04:44PM	Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin (GlobeNewswire)
Nov-13-23 09:55AM	How Much Upside is Left in Disc Medicine, Inc. (IRON)? Wall Street Analysts Think 38.17% (Zacks)
Nov-09-23 09:34AM	Disc Medicine Inc (IRON) Reports Q3 2023 Financial Results and Business Progress (GuruFocus.com)
08:30AM	Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-08-23 04:30PM	Disc Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 09:00AM	Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates (GlobeNewswire)
Oct-23-23 09:15AM	Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce (GlobeNewswire)
Oct-03-23 08:30AM	Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers (GlobeNewswire)
Sep-20-23 04:30PM	Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera (GlobeNewswire)
Aug-30-23 04:15PM	Disc Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 11:20AM	Stock Screen Finds These Growth Stocks Outperforming The S&P 500 (Investor's Business Daily)
Aug-11-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
08:00AM	Disc Medicine Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
09:00AM	Loading…
Jul-27-23 09:00AM	Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Jul-25-23 09:55AM	Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Jun-22-23 04:15PM	Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-20-23 07:33PM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks) +7.20%
Jun-13-23 10:39PM	Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Jun-12-23 04:00PM	Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.92%
01:59AM	4 big analyst picks: Adobe a buy on AI hopes, says Wells Fargo (Investing.com)
Jun-09-23 04:13PM	Why Perfectly Rated Disc Medicine, With A 287% Move This Year, Just Put Up Another Big Gain (Investor's Business Daily) +15.76%
07:00AM	Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
Jun-01-23 03:10PM	Why Shares of Disc Medicine Opco Climbed This Week (Motley Fool) +7.06%
May-31-23 04:00PM	Disc Medicine to Participate in the Jefferies Healthcare Conference (GlobeNewswire) +12.01%
May-15-23 07:00AM	Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-11-23 10:15AM	Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
May-10-23 10:23AM	Is a Surprise Coming for Disc Medicine (IRON) This Earnings Season? (Zacks) +5.24%
May-05-23 08:50AM	Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
May-04-23 12:00PM	Disc Medicine, Inc. (IRON) Is Up 4.40% in One Week: What You Should Know (Zacks)
Apr-28-23 05:00AM	Zacks.com featured highlights Harrow Health and Disc Medicine Opco (Zacks)
Apr-27-23 08:05AM	2 Stocks in Focus as Analysts Initiate Coverage (Zacks)
Apr-21-23 08:30AM	Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference (GlobeNewswire) +11.57%
Apr-19-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
Apr-13-23 11:00AM	Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP) (GlobeNewswire)
Mar-31-23 07:00AM	Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-30-23 07:05AM	Disc Medicine Opco Inc (NASDAQ:IRON) most popular amongst private equity firms who own 48% of the shares, institutions hold 21% (Simply Wall St.)
Mar-21-23 07:00AM	Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Feb-16-23 08:00AM	Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia (GlobeNewswire)
Feb-14-23 06:30AM	Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs (GlobeNewswire)
Feb-08-23 04:00PM	Disc Medicine to Participate in SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-20-23 07:00AM	Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis (GlobeNewswire)

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
White William Richard	Director	Apr 11 '24	Option Exercise	4.91	2,560	12,581	2,560	Apr 15 06:27 PM
White William Richard	Director	Apr 11 '24	Sale	31.80	2,560	81,407	0	Apr 15 06:27 PM
Savage William Jacob	Chief Medical Officer	Apr 10 '24	Option Exercise	2.65	21,870	57,956	43,405	Apr 11 05:02 PM
Bitterman Kevin	Director	Mar 05 '24	Sale	73.50	26,157	1,922,540	677,503	Mar 07 04:40 PM
Bitterman Kevin	Director	Jan 23 '24	Sale	67.65	102,500	6,934,125	198,326	Jan 25 04:33 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 23 '24	Sale	67.65	102,500	6,934,125	198,326	Jan 25 04:31 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 23 '24	Sale	67.65	47,500	3,213,375	1,402,186	Jan 25 04:31 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 10 '24	Sale	64.00	30,000	1,920,000	1,449,686	Jan 12 05:12 PM
Bitterman Kevin	Director	Jan 10 '24	Sale	64.00	20,000	1,280,000	786,160	Jan 12 05:12 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 10 '24	Sale	64.00	20,000	1,280,000	786,160	Jan 12 05:12 PM
Quisel John D	Chief Executive Officer	Dec 29 '23	Option Exercise	1.01	2,700	2,727	2,700	Jan 03 04:05 PM
Bryce Joanne	Chief Financial Officer	Dec 27 '23	Option Exercise	9.86	3,000	29,580	5,500	Dec 29 04:15 PM
Ashiya Mona	Director	Dec 18 '23	Option Exercise	38.00	1,724	65,512	1,724	Dec 20 06:16 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '23	Option Exercise	38.00	1,724	65,512	1,724	Dec 20 06:28 PM
Ashiya Mona	Director	Dec 18 '23	Sale	59.24	1,724	102,130	0	Dec 20 06:16 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '23	Sale	59.24	1,724	102,130	0	Dec 20 06:28 PM
ORBIMED ADVISORS LLC	Director	Dec 14 '23	Sale	56.75	433,200	24,584,100	224,405	Dec 15 06:04 PM
Ashiya Mona	Director	Dec 14 '23	Sale	56.75	433,200	24,584,100	224,405	Dec 15 06:09 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 14 '23	Sale	58.28	30,825	1,796,437	1,479,686	Dec 14 08:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 14 '23	Sale	58.28	20,549	1,197,567	806,160	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 14 '23	Sale	58.28	20,549	1,197,567	806,160	Dec 14 08:14 PM
ORBIMED ADVISORS LLC	Director	Dec 14 '23	Sale	57.73	200	11,546	727,807	Dec 14 05:44 PM
Ashiya Mona	Director	Dec 14 '23	Sale	57.73	200	11,546	727,807	Dec 14 05:40 PM
Ashiya Mona	Director	Dec 13 '23	Sale	58.56	106,700	6,248,352	281,505	Dec 14 05:40 PM
ORBIMED ADVISORS LLC	Director	Dec 13 '23	Sale	58.56	106,700	6,248,352	281,505	Dec 14 05:44 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 13 '23	Sale	60.00	5,323	319,357	1,510,511	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 13 '23	Sale	60.00	3,548	212,865	826,709	Dec 14 08:14 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 13 '23	Sale	60.00	3,548	212,865	826,709	Dec 14 08:13 PM
White William Richard	Director	Dec 12 '23	Option Exercise	6.08	33,511	203,883	33,511	Dec 14 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 12 '23	Option Exercise	2.65	2,500	6,625	5,000	Dec 14 04:15 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 12 '23	Sale	62.80	77,951	4,895,032	1,515,834	Dec 14 08:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 12 '23	Sale	62.80	51,967	3,263,328	830,257	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 12 '23	Sale	62.80	51,967	3,263,328	830,257	Dec 14 08:14 PM
White William Richard	Director	Dec 12 '23	Sale	63.21	33,511	2,118,239	0	Dec 14 04:15 PM
ORBIMED ADVISORS LLC	Director	Dec 12 '23	Sale	60.16	27,300	1,642,368	295,605	Dec 14 05:44 PM
Ashiya Mona	Director	Dec 12 '23	Sale	60.16	27,300	1,642,368	295,605	Dec 14 05:40 PM
Bryce Joanne	Chief Financial Officer	Dec 12 '23	Sale	65.22	2,500	163,062	2,500	Dec 14 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 05 '23	Option Exercise	1.01	1,281	1,294	5,041	Dec 07 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 05 '23	Sale	56.00	2,541	142,299	2,500	Dec 07 04:15 PM
Khara Rahul	General Counsel	Nov 22 '23	Option Exercise	14.69	10,000	146,900	10,000	Nov 27 04:15 PM
Khara Rahul	General Counsel	Nov 22 '23	Sale	51.73	10,000	517,333	0	Nov 27 04:15 PM
Khara Rahul	General Counsel	Nov 14 '23	Option Exercise	14.69	4,900	71,981	4,900	Nov 15 05:00 PM
Khara Rahul	General Counsel	Nov 14 '23	Sale	50.61	4,900	248,012	0	Nov 15 05:00 PM
Khara Rahul	General Counsel	Nov 03 '23	Option Exercise	14.69	100	1,469	100	Nov 07 06:22 PM
Khara Rahul	General Counsel	Nov 03 '23	Sale	50.00	100	5,000	0	Nov 07 06:22 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 16 '23	Sale	53.22	2,115	112,560	1,593,785	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 15 '23	Sale	53.16	260,894	13,869,125	1,595,900	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 14 '23	Sale	53.05	94,440	5,010,042	1,856,794	Sep 18 04:59 PM
Bryce Joanne	Chief Financial Officer	Sep 11 '23	Option Exercise	9.86	2,500	24,650	3,760	Sep 13 04:15 PM
Bryce Joanne	Chief Financial Officer	Sep 01 '23	Option Exercise	2.65	1,000	2,650	2,260	Sep 05 04:16 PM
Bryce Joanne	Chief Financial Officer	Sep 01 '23	Sale	52.99	1,000	52,990	1,260	Sep 05 04:16 PM
Savage William Jacob	Chief Medical Officer	Aug 21 '23	Option Exercise	2.65	3,000	7,950	3,000	Aug 22 04:06 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15 '23	Sale	52.40	111,069	5,820,016	1,951,234	Aug 16 06:55 PM
Bitterman Kevin	Director	Aug 15 '23	Sale	52.40	72,931	3,821,584	882,224	Aug 17 04:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15 '23	Sale	52.40	72,931	3,821,584	882,224	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 15 '23	Sale	52.95	7,672	406,235	0	Aug 16 04:15 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 14 '23	Sale	52.59	175,000	9,203,600	2,062,303	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 09 '23	Sale	49.83	8,269	412,064	7,672	Aug 11 04:15 PM
Bryce Joanne	Chief Financial Officer	Aug 01 '23	Option Exercise	1.01	4,521	4,566	5,781	Aug 03 04:18 PM
Bryce Joanne	Chief Financial Officer	Aug 01 '23	Sale	49.91	4,521	225,633	1,260	Aug 03 04:18 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 30 '23	Sale	45.05	4,324	194,778	12,876	Jun 30 06:29 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 29 '23	Sale	45.79	5,100	233,509	17,200	Jun 30 06:29 PM
Bryce Joanne	Chief Financial Officer	Jun 28 '23	Option Exercise	1.01	7,880	7,959	11,332	Jun 30 04:49 PM
Novo Holdings A/S	10% Owner	Jun 28 '23	Sale	46.10	1,250,000	57,625,000	1,090,772	Jun 28 05:04 PM
Bryce Joanne	Chief Financial Officer	Jun 28 '23	Sale	49.95	10,072	503,114	1,260	Jun 30 04:49 PM
MacDonald Brian Richard	Chief Innovation Officer	Jun 28 '23	Sale	49.96	5,100	254,795	22,300	Jun 30 06:29 PM
Savage William Jacob	Chief Medical Officer	Jun 28 '23	Sale	49.98	4,384	219,114	15,941	Jun 30 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRON

Disc Medicine Inc

Upgrade your FINVIZ experience